7Baggers
 INOVIO Reports Inducement Grant Under Inducement Plan  PR Newswire Thu, 02 Oct 2025 12:05:00 GMT
 here are the major earnings after the close tuesday  MSN Tue, 30 Sep 2025 13:45:51 GMT
 INOVIO stock slides after pricing $30M equity offering  MSN Mon, 29 Sep 2025 05:35:29 GMT
 biotech stocks positioned to transform treatment with next-gen therapeutics  FinancialContent Fri, 26 Sep 2025 15:24:00 GMT
 user  FinancialContent Fri, 26 Sep 2025 15:24:00 GMT
 INOVIO to Participate in Upcoming Scientific Conferences  PR Newswire Thu, 25 Sep 2025 12:05:00 GMT
 inato partners with realtime for clinical trial enrolment  Clinical Trials Arena Wed, 24 Sep 2025 10:59:46 GMT
 the outlook for precigen (nasdaq:pgen)  Seeking Alpha Tue, 23 Sep 2025 22:18:23 GMT
 lyme disease market: insights on epidemiology, treatments,  openPR.com Wed, 17 Sep 2025 23:08:04 GMT
 inovio rises after promising q2 results  MSN Tue, 16 Sep 2025 15:12:43 GMT
 published on: 2025-09-06 13:36:33  Newser Sat, 06 Sep 2025 18:36:33 GMT
 Inovio at H.C. Wainwright: Progress on DNA Medicine  Investing.com Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 16:02:26  Newser Tue, 02 Sep 2025 21:02:26 GMT
 published on: 2025-08-31 13:16:49  Newser Sun, 31 Aug 2025 18:16:49 GMT
 published on: 2025-08-31 08:49:19  Newser Sun, 31 Aug 2025 13:49:19 GMT
 published on: 2025-08-30 19:46:05  Newser Sun, 31 Aug 2025 00:46:05 GMT
 published on: 2025-08-29 13:58:14  Newser Fri, 29 Aug 2025 18:58:14 GMT
 published on: 2025-08-28 10:18:59  Newser Thu, 28 Aug 2025 15:18:59 GMT
 INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug  Yahoo Finance Thu, 28 Aug 2025 07:00:00 GMT
 inovio advances dna medicine for debilitating respiratory condition  Mugglehead Magazine Thu, 28 Aug 2025 07:00:00 GMT

Inovio Pharmaceuticals, Inc
(NASDAQ:INO) 

INO stock logo

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely design...

Founded: 1999
Full Time Employees: 190
CEO: J. Joseph Kim  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends